Shunji Haruta
Chief Tech/Sci/R&D Officer at SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Shunji Haruta active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Chief Tech/Sci/R&D Officer | 31/12/2010 | - |
| SATSUMA PHARMACEUTICALS, INC. | Director/Board Member | 07/06/2023 | - |
Career history of Shunji Haruta
Statistics
International
| Japan | 2 |
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Commercial Services |
| Private companies | 1 |
|---|---|
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Shunji Haruta
- Experience